ProMIS Neurosciences
(NASDAQ) PMN
ProMIS Neurosciences Financials at a Glance
Market Cap
$27.34M
Revenue (TTM)
$0.00
Net Income (TTM)
$39.72B
EPS (TTM)
$-23.42
P/E Ratio
-0.54
Dividend
$0.00
Beta (Volatility)
0.54 (Low)
Dividend
$0.00
Beta (Volatility)
0.54 (Low)
Price
$13.00
Volume
12,844
Open
$12.85
Price
$13.00
Volume
12,844
Open
$12.85
Previous Close
$13.00
Daily Range
$12.85 - $13.90
52-Week Range
$6.27 - $39.75
Dividend
$0.00
Beta (Volatility)
0.54 (Low)
Price
$13.00
Volume
12,844
Open
$12.85
Previous Close
$13.00
Daily Range
$12.85 - $13.90
52-Week Range
$6.27 - $39.75
PMN News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout ProMIS Neurosciences
Industry
Biotechnology
Sector
Health CareEmployees
11
CEO
Neil K. Warma, MBA
Website
www.promisneurosciences.comHeadquarters
Toronto, ON M4S 3E2, CA
PMN Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-522%
Return on Capital
33%
Return on Assets
-4%
Earnings Yield
-1.85%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$27.34M
Shares Outstanding
2.15M
Volume
12.84K
Short Interest
0.00%
Avg. Volume
174.18K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$40.17B
EBITDA
$55.11M
Operating Cash Flow
$28.12B
Capital Expenditure
$0.00
Free Cash Flow
$28.12B
Cash & ST Invst.
$6.15B
Total Debt
$0.00
ProMIS Neurosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$27.34M
N/A
Market Cap/Employee
$3.91M
N/A
Employees
7
N/A
Net Income
$39.69B
-16661921.7%
EBITDA
$14.78M
-6105.0%
Quarterly Fundamentals
Net Cash
$6.15B
+46058.9%
Accounts Receivable
$50.11K
-35.8%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-4.33%
N/A
Return on Invested Capital
32.67%
N/A
Free Cash Flow
$28.10B
-341191.4%
Operating Cash Flow
$28.10B
-341191.5%